The amyloid hypothesis for Alzheimer's disease: a critical reappraisal.
about
The Alzheimer's amyloid-degrading peptidase, neprilysin: can we control it?Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer's diseaseThe ER stress factor XBP1s prevents amyloid-beta neurotoxicityNovel therapeutics for Alzheimer's disease: an updateNeural stem/progenitor cells in Alzheimer's diseaseAlzheimer's disease: the silver tsunami of the 21(st) centuryDrug Development in Alzheimer's Disease: The Contribution of PET and SPECTOlive Oil and the Hallmarks of AgingExpanding the Repertoire of Biomarkers for Alzheimer's Disease: Targeted and Non-targeted ApproachesSuspected non-Alzheimer disease pathophysiology--concept and controversyTau Oligomers: The Toxic Player at Synapses in Alzheimer's DiseasePro-Apoptotic Kinase Levels in Cerebrospinal Fluid as Potential Future Biomarkers in Alzheimer's DiseaseThe 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairmentPrimate aging in the mammalian scheme: the puzzle of extreme variation in brain agingNew pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugsCalcium channel blockers and Alzheimer's diseaseAmyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's diseaseTherapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseAlzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasisDihydropyridine Derivatives Modulate Heat Shock Responses and have a Neuroprotective Effect in a Transgenic Mouse Model of Alzheimer's Disease.Can angiotensin-converting enzyme inhibitors impact cognitive decline in early stages of Alzheimer's disease? An overview of research evidence in the elderly patient populationModeling the complex pathology of Alzheimer's disease in DrosophilaAlzheimer's disease: Unique markers for diagnosis & new treatment modalitiesBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseAmyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent mannerAmyloid-β acts as a regulator of neurotransmitter release disrupting the interaction between synaptophysin and VAMP2Age-dependent neuroplasticity mechanisms in Alzheimer Tg2576 mice following modulation of brain amyloid-β levelsCyclic Ozone Exposure Induces Gender-Dependent Neuropathology and Memory Decline in an Animal Model of Alzheimer's DiseaseGenetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's diseasePrion protein-mediated toxicity of amyloid-β oligomers requires lipid rafts and the transmembrane LRP1Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disordersClusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathwayRobust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapyPresenilin deficiency or lysosomal inhibition enhances Wnt signaling through relocalization of GSK3 to the late-endosomal compartment.Brain-wide pathway for waste clearance captured by contrast-enhanced MRIAlzheimer amyloid beta inhibition of Eg5/kinesin 5 reduces neurotrophin and/or transmitter receptor function.Has inhibition of Aβ production adequately been tested as therapeutic approach in mild AD? A model-based meta-analysis of γ-secretase inhibitor data.Biomarkers in amyloid-β immunotherapy trials in Alzheimer's disease.Autism as early neurodevelopmental disorder: evidence for an sAPPα-mediated anabolic pathwayConvergent genetic and expression data implicate immunity in Alzheimer's disease
P2860
Q21296650-FF82F915-C3EA-4ABB-829C-89E13DBA3A44Q24293094-0536BAE0-BEF1-4C3A-90FD-2A5616B69C66Q24598012-B41D1B5C-8FAD-45F3-9EAE-A3DCA2FED24AQ24620383-10377743-C81F-4954-B90E-099F4871B991Q26738352-DD8F25D1-69DC-4183-9AD1-FDC7FDE41451Q26747610-212C87D8-48A8-4496-92E4-A08BC94589D7Q26749755-EF3C404B-5791-471B-A5DE-4240056AE228Q26769864-AFE33A02-1C1D-4DA7-BC0D-486B278DC86EQ26770708-88B26BC0-1261-4DCE-96A8-7C9B16D4E808Q26771270-CB6D09C7-147D-4B47-96A6-71C3102083EEQ26773154-BFAE6AD2-67F3-418C-8329-A35CB0C4F32CQ26795492-C3152056-22A4-412C-B7AD-D8A55F4B5878Q26827320-35303A73-A8C3-4751-BCD0-4F462C2BE57DQ26865145-700C3D14-FD09-44E6-9D30-7CF59B02EFB0Q26866006-663D5004-866A-4EC7-82D8-FF50AB96BAD4Q26866552-4FE71C06-E931-4E3B-8B65-DC64CAC75E6CQ27012950-D3FB544F-FBF7-48EC-B87B-4CF8582C7E5DQ27021700-65E4B0E8-49E3-4D7D-BAAD-9883831BDA64Q27024824-5B442568-AC22-4876-9F54-7EE13CC4D70FQ27333755-FE6FD772-64DE-49BA-9001-906DC9DBC836Q28077087-B78C4111-FA49-4064-9AF4-9AF6333DD265Q28082451-877F669E-0728-4281-8636-674B44FCEAF8Q28085139-5018FB09-83D3-4287-AF1E-4FB13DC41F7CQ28259585-FAC45D37-B991-475F-A80C-D08E3C969314Q28476620-9FC2919C-AC8A-4FD8-BADB-120917FE16B6Q28482267-5DBF2579-D25C-4794-935E-174D36C25EC1Q28488088-C852B56F-0765-4F2A-BD50-B29A6805BC21Q28611230-C4B8C281-23EA-4C74-8744-14A41196FE6FQ28748461-E2BD39B5-3FAD-4FF0-A491-9814258EDE93Q28910209-A3465C8F-419E-46E5-89EC-956CCBE13C7AQ29615839-2F419517-145C-4B75-8CB2-8E75BDE3B205Q29870999-914E8A9A-2F8E-4B33-ACAF-C4BD998F50DDQ30499456-051F6B69-483E-4D7D-B1B9-C77B40F8724DQ30531717-AE60143E-8BF1-45B0-9BF9-31F70FB1FE30Q30536631-DCC5549C-0F47-4208-9F47-463E922282E0Q30583064-C13D8DA1-8B00-4F51-B774-AC229DCB65F9Q30584453-97309371-0921-4A72-926A-66C0DC5F7E45Q30651551-7C57E65D-06D3-469E-840F-3848617990B1Q30651711-7DA63A72-EE4F-460C-AC6F-D2C52F310E99Q30881547-DBE31B8C-8B03-446B-AD10-9BB235BD4F57
P2860
The amyloid hypothesis for Alzheimer's disease: a critical reappraisal.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The amyloid hypothesis for Alzheimer's disease: a critical reappraisal.
@en
The amyloid hypothesis for Alzheimer's disease: a critical reappraisal.
@nl
type
label
The amyloid hypothesis for Alzheimer's disease: a critical reappraisal.
@en
The amyloid hypothesis for Alzheimer's disease: a critical reappraisal.
@nl
prefLabel
The amyloid hypothesis for Alzheimer's disease: a critical reappraisal.
@en
The amyloid hypothesis for Alzheimer's disease: a critical reappraisal.
@nl
P1476
The amyloid hypothesis for Alzheimer's disease: a critical reappraisal.
@en
P304
P356
10.1111/J.1471-4159.2009.06181.X
P407
P577
2009-05-18T00:00:00Z